Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pharma-Bio Serv (PBSV) Leases (2016 - 2025)

Pharma-Bio Serv's Leases history spans 12 years, with the latest figure at $29388.0 for Q4 2025.

  • For Q4 2025, Leases fell 85.2% year-over-year to $29388.0; the TTM value through Oct 2025 reached $29388.0, down 85.2%, while the annual FY2025 figure was $29388.0, 85.2% down from the prior year.
  • Leases reached $29388.0 in Q4 2025 per PBSV's latest filing, down from $72747.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $790561.0 in Q1 2021 to a low of $29388.0 in Q4 2025.
  • Average Leases over 5 years is $409359.8, with a median of $412419.0 recorded in 2023.
  • Peak YoY movement for Leases: fell 12.97% in 2021, then plummeted 85.2% in 2025.
  • A 5-year view of Leases shows it stood at $639969.0 in 2021, then dropped by 21.45% to $502685.0 in 2022, then fell by 29.09% to $356450.0 in 2023, then crashed by 44.28% to $198597.0 in 2024, then tumbled by 85.2% to $29388.0 in 2025.
  • Per Business Quant, the three most recent readings for PBSV's Leases are $29388.0 (Q4 2025), $72747.0 (Q3 2025), and $115259.0 (Q2 2025).